Access cutting-edge diabetic neuropathy treatment through this clinical trial at a research site in Roswell. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Roswell location
Preparing your pre-screening questions…
Access diabetic neuropathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic neuropathy treatment provided free
Check if you qualify for this diabetic neuropathy clinical trial in Roswell, GA
No-Cost Study Care
Local to Roswell
Convenient for GA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Distal symmetric polyneuropathy, also known as diabetic neuropathy, is the most common neurological complication of diabetes and a main cause of morbidity. The condition leads to gradual loss of function of the longest nerve fibers that limits function and decreases quality of life. Symptoms present distally and symmetrically in toes and feet. Symptoms of the neurologic disability include sensory loss, risk of foot ulcers and limb amputations and pain. The condition is not generally considered reversible, and condition management aims to slow progression and prevent complications. According to estimates from the International Diabetes Federation, diabetic neuropathy affected approximately 425 million people in 2017, with projections indicating a rise to 628 million by 2045. Despite the high prevalence of this condition, it is commonly misdiagnosed and has limited treatment options. There are multiple phenotypes of diabetic neuropathy, with the most common form being distal symmetric sensorimotor polyneuropathy, which is what we will be focusing on in this study. The proposed study seeks to evaluate the effectiveness of a non-compressive therapeutic socks throughout a 12-week course of rehabilitation for managing distal symmetric polyneuropathy. Outcome measures will be collected at standard intervals and compared with pre-treatment measures to evaluate effectiveness of treatment.
Sponsor: Endocrine Research Solutions
Yes, this clinical trial (NCT06452914) has an active research site in Roswell, GA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for diabetic neuropathy treatment options in Roswell, GA, this clinical trial (NCT06452914) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Roswell research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all diabetic neuropathy clinical trials near you to find additional studies recruiting in your area.
See all neuropathy clinical trials recruiting in Roswell — not just this study.
Browse Neuropathy Trials in Roswell →